AstraZeneca must deliver vaccine doses from UK to EU, says Von der Leyen | Ursula von der Leyen

Join Hafta-Ichi to Research the article “AstraZeneca must deliver vaccine doses from UK to EU, says Von der Leyen | Ursula von der Leyen”

Ursula von der Leyen has said it is “crystal clear” that AstraZeneca is bound by its contract to deliver coronavirus vaccine doses produced in the UK to the EU to make up for a shortfall in production in Belgium.

As AstraZeneca agreed to publish a redacted version of its contract with the European commission on Friday, the commission’s president dismissed the arguments of AstraZeneca’s chief executive, Pascal Soriot, that the British government had a first claim on doses produced in Oxford and Staffordshire.

Von der Leyen said the Anglo-Swedish pharmaceutical company was legally obliged to use all four plants named in its contract – two in the UK, one in Belgium and a fourth in the Netherlands – to deliver on its promised order.

The European commission has paid €336m for 400m doses, the first 100m of which were due to be delivered in the first quarter of this year.

Last week the company enraged officials by announcing that only 25% of the deliveries would be possible owing to production problem at the Belgian plant, and that it could not make good on the shortages by importing from the UK.

Von der Leyen told the German radio station Deutschlandfunk that the company’s stance was unacceptable. “There are binding orders and the contract is crystal clear,” she said. “AstraZeneca has also explicitly assured us in this contract that no other obligations would prevent the contract from being fulfilled.”

She said the “best effort” clause in the AstraZeneca contract with the EU was supposed to refer to the period during which the company was developing the vaccine. “This is now in the past. The vaccine is there. It still has to go through the approval process. Once a vaccine is there, there were very clear rules regarding amounts as well as timeframes – they are in the contract – and there are also locations where the vaccine should be produced.

“And it’s important, after the comments of the company boss, that we make this contract public so we can be transparent with citizens as to what was in this contract.”

Speaking after the publication of the contract, Eric Mamer, the commission’s chief spokesman, said: “We have always said that indeed there are a number of plants which are mentioned in the contract that we have with AstraZeneca, some of which are located in the UK, and it is foreseen that these plants will contribute to the effort of AstraZeneca to deliver doses to the European Union. There is absolutely no question for us that this is what the contract specifies.”

Britain said it could not publish details of its AstraZeneca supply contract because it would jeopardise national security, a junior minister said on Friday.

The Oxford/AstraZeneca vaccine is expected to be authorised for use without restrictions by the European Medicines Agency on Friday, and advance orders of the doses were considered key to building momentum in the bloc’s vaccination effort. Just 2% of the EU adult population have received a vaccine jab, compared with 11% of those in the UK.

The lack of doses in the EU has already forced the Spanish government to announce a temporary pause in its rollout of the vaccine in Madrid, and to warn that Catalonia could follow.

The public health agency for Paris and the surrounding region, an area with a population of 12.1 million people, informed hospitals on Thursday that it would suspend its programme from 2 February. Hospitals in the Hauts-de-France region were told that the deployment of first doses there would be delayed to the first week of March.

Germany’s health minister, Jens Spahn, said on Friday: “We still have some difficult weeks of vaccine shortages ahead of us.”

The European commission will announce details on Friday of an export authorisation system that would allow member states to block vaccine doses from leaving its territory, raising concerns over the continued supply of the Pfizer/BioNTech vaccine, for which the UK has a 40m-dose order.

Additional reporting by Kate Connolly

Hafta Ichi
Source: The Guardian
Keyword: AstraZeneca must deliver vaccine doses from UK to EU, says Von der Leyen | Ursula von der Leyen

Leave a Comment

Your email address will not be published. Required fields are marked *